Polaris AI Pharma Corp
041910
Company Profile
Business description
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.
Contact
25 Balangongdan-ro, Hyangnam-eup
Gyeonggi-do
Hwaseong-si
KORT: +82 318314800
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
162
Stocks News & Analysis
stocks
More gas left in the tank for ASX highflyer
Shares jumped after results and are screening as overvalued.
stocks
Ahead of Earnings, is Apple stock a buy, a sell, or fairly valued?
Following strong holiday sales and a recent AI deal, here’s what we’re watching for in Apple’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,189.90 | 15.70 | 0.17% |
| CAC 40 | 8,131.08 | 11.97 | -0.15% |
| DAX 40 | 24,886.74 | 13.97 | -0.06% |
| Dow JONES (US) | 49,098.71 | 285.30 | -0.58% |
| FTSE 100 | 10,144.09 | 0.65 | 0.01% |
| HKSE | 26,765.52 | 16.01 | 0.06% |
| NASDAQ | 23,501.24 | 65.22 | 0.28% |
| Nikkei 225 | 52,885.25 | 961.62 | -1.79% |
| NZX 50 Index | 13,460.74 | 12.50 | 0.09% |
| S&P 500 | 6,915.61 | 2.26 | 0.03% |
| S&P/ASX 200 | 8,860.10 | 15.00 | 0.17% |
| SSE Composite Index | 4,132.60 | 3.56 | -0.09% |